Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Current Leases (2019 - 2021)

Historic Current Leases for Cyclerion Therapeutics (CYCN) over the last 3 years, with Q1 2021 value amounting to $1.4 million.

  • Cyclerion Therapeutics' Current Leases fell 4752.62% to $1.4 million in Q1 2021 from the same period last year, while for Mar 2021 it was $1.4 million, marking a year-over-year decrease of 4752.62%. This contributed to the annual value of $3.3 million for FY2020, which is 371.35% down from last year.
  • Cyclerion Therapeutics' Current Leases amounted to $1.4 million in Q1 2021, which was down 4752.62% from $3.3 million recorded in Q4 2020.
  • Cyclerion Therapeutics' Current Leases' 5-year high stood at $3.4 million during Q4 2019, with a 5-year trough of $866000.0 in Q2 2019.
  • For the 3-year period, Cyclerion Therapeutics' Current Leases averaged around $2.6 million, with its median value being $3.0 million (2020).
  • Per our database at Business Quant, Cyclerion Therapeutics' Current Leases soared by 22182.45% in 2020 and then plummeted by 4752.62% in 2021.
  • Over the past 3 years, Cyclerion Therapeutics' Current Leases (Quarter) stood at $3.4 million in 2019, then dropped by 3.71% to $3.3 million in 2020, then crashed by 57.49% to $1.4 million in 2021.
  • Its last three reported values are $1.4 million in Q1 2021, $3.3 million for Q4 2020, and $3.1 million during Q3 2020.